Guest guest Posted February 28, 2012 Report Share Posted February 28, 2012 Here is the latest information on the secondary trial for LDN (Low Dose Naltrexone) and Fibromyalgia patients conducted by Stanford University. http://www.medpagetoday.com/MeetingCoverage/AAPM/31371 Judy H To Health Through Knowledge Started taking Low Dose Naltrexone on January 20, 2009 for Fibromyalgia, Restless Legs Syndrome, Hashimotos Thyroid and PCOS http://health.groups.yahoo.com/group/LDNforFibro/ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.